Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer

June 12, 2024

https://www.prnewswire.com/news-releases/flagship-pioneering-and-profound-therapeutics-announce-agreement-to-identify-novel-first-in-class-therapeutics-for-the-treatment-of-obesity-under-strategic-partnership-with-pfizer-302170276.html

Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
/PRNewswire/ — Flagship Pioneering and ProFound™ Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines…
https://www.prnewswire.com/news-releases/flagship-pioneering-and-profound-therapeutics-announce-agreement-to-identify-novel-first-in-class-therapeutics-for-the-treatment-of-obesity-under-strategic-partnership-with-pfizer-302170276.html

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.